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Abstract
Background: As obesity is rapidly becoming a major medical and public health problem, the aim
of our study was to determine: 1) if obesity in Caucasian adolescents at 5 different Tanner stages
are associated with obesity in adulthood and its obesity-associated abnormal glucose and lipid
profiles, 2) the type of fat distribution is associated with glucose and lipid profile abnormalities, and
3) the risk level and the age of appearance of these abnormalities.
Methods: For the first study, data analyses were from a case-control study of adolescents classified
according to their BMI; a BMI  85th percentile for age and sex as overweight, and those with a BMI
 95th percentile as obese. Subjects with a BMI < 85th percentile were classified as controls.
WC:AC ratio of waist circumference to arm circumference was used as an indicator of a central
pattern of adiposity. Two other indices of central adiposity were calculated from skinfolds: Central-
peripheral (CPR) as subscapular skinfold + suprailliac skinfold)/ (triceps skinfold + thigh skinfold)
and ratio of subscapular to triceps skinfold (STR). The sum of the four skinfolds (SUM) was
calculated from triceps, subscapular, suprailliac and thigh skinfolds. SUM provides a single measure
of subcutaneous adiposity. Representative adult subjects were used for comparison. Glucose and
lipid profiles were also determined in these subjects. Abnormal glucose and lipid profiles were
determined as being those with fasting glucose  6.1 mmol/l and lipid values  85th percentile
adjusted for age and sex, respectively. Prevalence and odds ratio analysis were used to determine
the impact of obesity on glucose and lipid profiles at each Tanner stages for both sexes. Correlation
coefficient analyses were used to determine the association between glucose and lipid profiles and
anthropometric measurements for both sexes. The second study evaluated in a retrospective-
prospective longitudinal way if: 1) obesity in adolescence is associated with obesity in adulthood
and 2) the nature of obesity-associated risk factors. Incidence and odds ratio analysis were used to
determine the impact of obesity on glucose and lipid profiles at 7 different age groups from 9 to 38
years old in both sexes between 1974 to 2000.
Results:  Overall, glucose and lipid profiles were significantly (P < 0.01) associated with all
anthropometric measurements either in male and female adolescents. WC:AC, CPR, STR and SUM
are stronger predictors of both glucose and lipid profiles than BMI. Obese and overweight
adolescents of Tanner stages III and higher are at increased risk of having an impaired glucose and
lipid profiles than normal subjects with odds ratios of 5.9 and higher. Obesity in adolescents of 13–
15 years old group is significantly (P < 0.01) associated with obesity in adulthood (with odds ratios
of at least 12 for both men and women) and abnormal glucose (odds ratio of  8.6) and lipid profiles
(odds ratio of  11.4).
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Conclusions: This study confirmed that adolescents aged between 13 and 15 years old of both
sexes with a BMI  85th percentile are at increased risk of becoming overweight or obese adults
and presenting abnormal glucose and lipid profiles as adults. This emphasizes the importance of
early detection and intervention directed at treatment of obesity to avert the long-term
consequences of obesity on the development of cardiovascular diseases.
Background
Obesity is rapidly becoming one of the most important
medical and public health problems of our time. Obesity
is associated with a high rate of morbidity and early mor-
tality if left untreated [1–4]. Studies indicate that the pres-
ence of obesity increases the risk for developing
cardiovascular diseases and diabetes [5–8]. Its role as a
health hazard in adults has been well recognized for some
time [1–13] but little attention has been paid to child-
hood and adolescent obesity [14–17].
The prevalence of obesity among US children is approxi-
mately of 22–30% and has increased at an accelerating
rate in the past several years [18–20]; the prevalence of
obesity is > 30% in some pediatric populations [20,21].
Obesity in childhood is associated with obesity in adult-
hood [22–25], and is a predictor of all causes of obesity-
associated mortality during adulthood, particularly mor-
tality from cardiovascular diseases, which are independ-
ent of adult weight [24,25]. Epidemiologic evidence
supports the theory that the relation between obesity and
disease risk begins early in life. For instance, adolescents
who died in accidents had fatty streaks in the coronary ar-
teries and aorta that were found at, autopsy, and were as-
sociated with blood lipid profile, blood pressure, and
obesity status obtained at one or more points antemortem
[26,27]. Moreover, a recent longitudinal study indicated
that the occurrence of overweight, hypertension, and dys-
lipidemia in young adults (aged 19–32 y) was associated
with these same risk factors in childhood. Data from the
Children's Hospital Medical Center in Cincinnati have
shown that the incidence of type 2 diabetes among ado-
lescents increased 10-fold from 1982 to 1994, and virtual-
ly all diagnosed cases of type 2 diabetes occurred in obese
individuals [28]. These observations are likely to reflect
national trends and certainly deserve both confirmation,
and a sharper focus.
To test the hypothesis that being an overweight or obese
adolescent is associated with early appearance of glucose
and lipid profile abnormalities, we performed a case-con-
trol study quantifying the odds ratio of overweight and
obesity on these abnormalities through different Tanner's
stages. The association between glucose and lipid profiles
and the distribution of adipose tissue was also tested in
this study. The objective of the second study was to deter-
mine. from a retrospective-prospective longitudinal study
of overweight and obese male and females having abnor-
mal glucose and/or lipid profiles at which age obesity in
adolescence can be predictive of adult obesity and its
obesity-associated cardiovascular risk factors.
Methods
Study 1
The first investigation was designed as a case-control study
and was performed in hospitals associated with Montreal
and McGill Universities. Many of the subjects were also di-
rectly recruited from nursery schools. This study was con-
ducted to determine the relationship between various
indicators of adiposity and risk factors for cardiovascular
diseases in Caucasian normal, overweight, and obese
male and female adolescents. The prevalence and odds ra-
tio of being overweight or obese on glucose and lipid pro-
files was also determined. Each Tanner stage is associated
with important changes in genital development and sexu-
al hormone profiles, which could have an impact on adi-
pose tissue distribution and glucose and lipid profiles.
Informed written consent was obtained from the parents
and/or of all participating subjects. The participants were
recruited from local and national advertising. To be in-
cluded in the study, adolescents and adults had to meet
the following criteria: 1) be of Caucasian ethnicity; 2) be
free from diagnosed endocrine conditions that could lead
to obesity, and 3) not taking any medication affecting
body weight. They were selected for the study on the basis
of their body mass index. Standing height was measured
with a wall-mounted tape, and weight was measured with
the same standard balance scale.
Adolescents were classified according to BMI;  85th per-
centile as overweight, and  95th percentile for age and sex
as obese [29–32]. Recent workshops concluded that the
BMI has been validated by studies on total body fat [32].
The standards used to identify overweight and obesity in
children and adolescents should agree with the standards
used to identify grade 1 and grade 2 overweight (BMI of
25 and 30, respectively) in adults [33]. Adolescents with a
BMI < 85th percentile were classified as controls (Group
1), Group 2 were overweight (BMI > 85th percentile and <
95th percentile) and group 3 were obese (BMI  95th per-
centile). Adults with a BMI < 25 were classified as controls,
between 25 and 30 as overweight and  30 as obese. Sexes
were grouped separately.BMC Family Practice 2002, 3 http://www.biomedcentral.com/1471-2296/3/18
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Table 1: Anthropometric measurements with categories of BMI and Tanner stages. A group of adults was also used for comparison 
purpose. Adults with a BMI < 25 were classified as controls, between 25 and 30 as overweight and  30 as obese. A BMI of 25 and 30 
correspond to 85th and 95th percentile respectively.
Tanner's Stage Age (years) BMI(%) WC:AC (ratio) CPR (ratio) STR (Index) SUM
Male
Tanner I
Normal (n = 38) 10.7  0.4 76.7  1.8 2.3  0.05 1.3  0.04 0.7  0.02 51  6
Overweight (n = 36) 10.8  0.5 87.2  1.0 3.0  0.07 1.7  0.04 0.9  0.02 70  9
Obese (n = 34) 10.6  0.6 96.7  1.1 3.4  0.07 2.2  0.05 1.3  0.04 86  11
Tanner II
Normal (n = 35) 11.9  0.6 76.4  2.0 2.4  0.03 1.2  0.03 0.6  0.02 47  8
Overweight (n = 32) 11.8  0.6 88.3  1.4 3.1  0.06 1.7  0.05 0.9  0.02 76  8
Obese (n = 35) 11.8  0.5 97.1  1.0 3.6  0.05 2.3  0.03 1.4  0.03 90  7
Tanner III
Normal (n = 39) 13.3  0.7 77.4  2.3 2.4  0.02 1.4  0.04 0.8  0.03 49  8
Overweight (n = 36) 13.2  0.6 88.9  1.1 3.3  0.07 2.0  0.04 1.3  0.02 85  10
Obese (n = 36) 13.3  0.5 97.4  0.9 4.2  0.09 2.5  0.05 1.8  0.03 110  9
Tanner IV
Normal (n = 33) 13.9  0.5 78.1  3.2 2.5  0.05 1.5  0.03 0.8  0.02 53  8
Overweight (n = 31) 14.0  0.5 90.0  1.1 3.4  0.08 2.1  0.03 1.4  0.03 88  12
Obese (n = 33) 13.8  0.6 96.8  0.4 4.1  0.09 2.6  0.05 1.9  0.02 108  11
Tanner V
Normal (n = 38) 14.6  0.3 79.5  2.4 2.5  0.04 1.4  0.04 0.7  0.03 54  7
Overweight (n = 35) 14.6  0.5 87.4  0.8 3.4  0.05 2.1  0.05 1.3  0.02 86  12
Obese (n = 36) 14.7  0.4 96.6  0.4 3.9  0.08 2.6  0.06 2.0  0.02 115  14
ADULTS
Normal (n = 44) 31.2  0.3 22.2  0.5 2.4  0.03 1.4  0.04 0.7  0.02 54  8
Overweight (n = 43) 30.6  0.6 28.4  0.8 4.1  0.05 2.4  0.06 1.5  0.02 106  12
Obese (n = 45) 31.5  0.4 33.6  0.4 4.9  0.07 2.9  0.05 2.4  0.02 145  14
Female
Tanner I
Normal (n = 35) 10.3  0.5 76.3  2.8 2.3  0.05 1.2  0.04 0.8  0.01 48  5
Overweight (n = 30) 10.3  0.6 88.2  1.0 2.9  0.07 1.6  0.04 0.9  0.02 72  8
Obese (n = 33) 10.2  0.5 96.0  0.3 3.4  0.09 1.9  0.03 1.0  0.03 88  7
Tanner II
Normal (n = 31) 11.4  0.6 77.3  2.0 2.4  0.04 1.3  0.04 0.8  0.02 54  9
Overweight (n = 32) 11.3  0.5 89.1  1.9 3.2  0.06 1.9  0.05 1.2  0.02 78  8
Obese (n = 29) 11.4  0.7 97.4  0.6 3.7  0.08 2.2  0.04 1.5  0.03 90  9
Tanner III
Normal (n = 37) 12.9  1.0 77.6  3.0 2.4  0.04 1.3  0.03 0.8  0.03 55  9
Overweight (n = 33) 12.8  0.9 91.6  2.0 3.5  0.07 2.2  0.05 1.1  0.04 82  7
Obese (n = 32) 12.9  0.7 97.5  0.5 4.1  0.07 2.5  0.04 1.5  0.03 105  10
Tanner IV
Normal (n = 32) 13.6  0.7 79.1  1.8 2.3  0.06 1.4  0.05 0.9  0.02 49  6
Overweight (n = 29) 13.7  0.8 90.4  0.7 3.6  0.07 2.3  0.04 1.2  0.04 90  11
Obese (n = 28) 13.8  0.7 96.8  0.9 4.0  0.06 2.5  0.05 1.5  0.03 108  9
Tanner V
Normal (n = 33) 14.7  0.7 79.3  2.5 2.4  0.07 1.3  0.03 1.0  0.03 49  6
Overweight (n = 34) 14.6  0.8 89.9  2.0 3.6  0.06 2.2  0.04 1.3  0.03 92  9
Obese (n = 34) 14.7  0.7 97.0  0.4 3.9  0.06 2.5  0.04 1.6  0.03 107  8
ADULTS
Normal (n = 40) 33.4  0.3 22.2  0.4 2.4  0.02 1.3  0.03 0.7  0.01 54  5
Overweight (n = 42) 31.2  0.5 27.8  0.6 4.3  0.05 2.7  0.05 1.4  0.02 116  16
Obese (n = 40) 33.5  0.5 32.6  0.5 4.7  0.07 3.0  0.06 2.6  0.03 150  17
The results are expressed as means  SD. P < 0.01 Normal vs overweight and P < 0.001 Normal vs Obese for either male and female. There is no 
differences between males and females for the variables measured WC:AC: waist to arm circumference. CPR: subscapular skinfold + suprailliac 
skinfold) / (triceps skinfold+ thigh skinfold), STR: ratio of subscapular to triceps skinfold, SUM:triceps, subscapular, suprailliac and thigh skinfolds in 
the total sample.BMC Family Practice 2002, 3 http://www.biomedcentral.com/1471-2296/3/18
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Table 2: Prevalence of impaired fasting glucose and lipid profile by categories of BMI in adolescents at different Tanner's stages and sex. 
A group of adults was used for comparison purpose.
Impaired glucose profile Impaired lipid profile
Tanner's Stages N No Cases Prevalence (%) No Cases Prevalence (%)
Male
Tanner I
N o r m a l 3 8 0000
Overweight 36 4 11.1 0 0
Obese 34 15 44.1 4 11.7
Tanner II
N o r m a l 3 5 0000
Overweight 32 5 15.6 0 0
Obese 35 13 37.1 4 11.4
Tanner III
Normal 39 4 10.3 3 7.7
Overweight 36 13 36.1 13 36.1
O b e s e 3 6 2 87 7 . 71 85 0 . 0
Tanner IV
Normal 33 3 9.1 5 15.2
Overweight 31 14 45.1 14 45.1
O b e s e 3 3 3 19 4 . 03 28 8 . 8
Tanner V
Normal 38 5 13.2 6 15.8
Overweight 35 13 37.1 14 40.0
Obese 36 36 100 32 88.8
ADULTS
Normal 44 6 13.6 6 13.6
Overweight 43 18 41.8 17 39.5
Obese 45 42 100 42 93.3
Female
Tanner I
N o r m a l 3 5 0000
Overweight 30 3 10 0 0
Obese 33 12 36.4 4 12.1
Tanner II
N o r m a l 3 1 0000
Overweight 32 4 12.5 0 0
Obese 29 13 44.8 4 13.8
Tanner III
Normal 37 5 13.5 5 13.5
Overweight 33 12 36.4 13 39.4
O b e s e 3 2 2 68 1 . 31 85 6 . 3
Tanner IV
Normal 32 4 12.5 4 12.5
Overweight 29 17 58.6 14 48.2
O b e s e 2 8 2 48 5 . 72 58 6 . 2
Tanner V
Normal 33 4 12.1 5 15.2
Overweight 34 13 38.2 14 41.1
O b e s e 3 4 2 98 5 . 33 19 1 . 1
ADULTS
Normal 40 6 15.0 6 15.0
Overweight 42 17 40.5 17 40.5
Obese 40 40 100 37 92.5BMC Family Practice 2002, 3 http://www.biomedcentral.com/1471-2296/3/18
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WC:AC was calculated from the ratio of waist circumfer-
ence to arm circumference and used as a measured of fat
distribution analogous to waist to hip ratio, on the as-
sumption that a higher ratio of waist to arm circumference
is an indicator of a more central pattern of adiposity. We
used this measure in preference to waist to hip ratio, be-
cause a study which determined peripheral and abdomi-
nal adipose tissue content in children using magnetic
resonance imaging found that WC:AC correlated positive-
ly with intra-abdominal adipose tissue (r  0.63, P =
0.001) while waist to hip ratio did not (r = 0.11) [34]. Two
other indices of central adiposity were calculated from
skinfolds: Central-peripheral (CPR) as subscapular skin-
fold + suprailliac skinfold) / (triceps skinfold+ thigh skin-
fold) and ratio of subscapular to triceps skinfold (STR).
STR is an index of relative distribution of central subcuta-
neous adiposity. The sum of the four skinfolds (SUM) was
calculated from triceps, subscapular, suprailliac and thigh
skinfolds in the total sample. The SUM provides a single
measure of subcutaneous adiposity. Anthropometric
measurements were done by the same experienced evalu-
ator to reduce variability which was measured at less than
0.5%.
Table 3: Sensitivity, specificity, and odds ratios for impaired glucose profile (IGP) vs normal glucose profile (NGP) levels for both sex at 
Tanner's stages 3 to 5 with a selected cutoff point for BMI values at the 85th percentile.
Tanner's stages Cutoff point for BMI values Sensitivity Specificity Odds ratio
> 85th < 85th.
Tanner III
Males
IGP(n = 47) 43 4 91%
NGP (n = 54) 19 35 64.8%
Total (n = 101) 62 39 19.6
Females
IGP(n = 43) 38 5 88.4%
NGP (n = 44) 12 32 72.7 %
Total (n = 87) 50 37 20.3
Tanner IV
Males
IGP(n = 48) 45 3 93.5%
NGP (n = 48) 18 30 71.4%
Total (n = 96) 63 33 23.7
Females
IGP(n = 45) 41 4 93.2%
NGP (n = 45) 17 29 64.4%
Total (n = 90) 58 32 17.5
Tanner V
Males
IGP(n = 54) 49 5 90.7%
NGP (n = 55) 22 33 60%
Total (n = 109) 71 38 14.7
Females
IGP(n = 46) 42 4 87.9%
NGP (n = 55) 26 29 61.8%
Total (n = 101) 68 33 11.7
Adults
Males
IGP(n = 69) 63 6 86.4%
NGP (n = 63) 25 38 64.3%
Total (n = 132) 98 44 16.0
Females
IGP(n = 63) 57 6 85%
NGP (n = 59) 25 34 69.5%
Total (n = 122) 82 40 12.9
An odds ratio of 19.6 means that the risk of IFG is 19.6 times higher in Tanner's stage 3 adolescents who are having a BMI > 85th than in those with 
a BMI < than 85th percentile.BMC Family Practice 2002, 3 http://www.biomedcentral.com/1471-2296/3/18
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Genital development was evaluated with the criteria of
Tanner [35], and was performed with a questionnaire and
physical exam by an experienced physician, in which stage
1 is prepubertal, stage 2 is initial development of the gen-
italia, stages 3 and 4 are intermediate, and stage 5 is ma-
ture. Stage of sexual maturation in the girls was
determined on the basis of a combination of menarcheal
status and breast and pubic hair development [36]. The
stages of sexual maturation were performed with a ques-
tionnaire and physical exam done by an experienced phy-
sician as follow: premenarcheal with no secondary sexual
development (stage 1). Premenarcheal with some second-
ary sexual development (stage 2); premenarcheal at the
time of study but attained menarche within 6 months
(stage 3); postmenarcheal with secondary sexual develop-
ment not yet mature (stage 4); and postmenarcheal with
secondary sexual development (stage 5).
The subjects were instructed to arrive to the clinic at 8:00
AM after 12-hour overnight fast. BMI was measured and a
venous blood sample was taken followed by a breakfast.
Fasting blood samples were stored at 4C. Serum glucose
and insulin levels and lipid profile were determined. They
completed a questionnaire on risk factors for atheroscle-
rosis including family history of coronopathy, smoking,
high blood pressure, personal history of coronopathy or
myocardial infarct, history of cerebrovascular disease or
occlusive peripheral disease. Most overweight and obese
subjects had at least two risk factors for atherosclerosis.
The diagnostic criteria for glucose profile were those ap-
proved by the American Diabetes Association [37]. Diabe-
tes is defined as a fasting serum glucose equal or higher
than 7 mmol/L (126 mg/dl) and impaired fasting glucose
with values between 6.0 and 7.0 mmol/L. Subjects with
high fasting glucose levels were referred to their own phy-
sicians for further clinical evaluation.
Lipid profile was also performed on the fasting blood
sample. The blood lipid variables investigated were trig-
lyceride (TRG), total cholesterol (TC), high-density lipo-
protein (HDL) cholesterol concentrations, low-density
lipoproteins (LDL) cholesterol concentrations and the ra-
tio of total:HDL cholesterol (T:HDLC) [38]. All biochem-
ical measurements were performed in an accredited
hospital laboratory.
Study 2
The second investigation was designed as a retrospective-
prospective longitudinal study from 1974 to 2000 and
was performed from hospitals associated with Montreal
and McGill Universities. This study was conducted to de-
termine the age of apparition of abnormal glucose and li-
pid profiles in a group of overweight and obese young
Caucasians adults presenting abnormal glucose and/or li-
pid profiles. The study was performed from chart review
of participants. 2000 charts were pre-selected by the archi-
vists. To be included in the study, young adults had to
meet the following criteria: 1) be of Caucasian ethnicity;
2) be between the ages of 32–38 y; 3) be free from diag-
nosed endocrine conditions that could have led to obesi-
ty, 4) not having taken any medication affecting body
weight, 5) presenting a BMI  25 at adult age; 6) present-
ing abnormal glucose and/or lipid profiles; 7) presenting
at least 2 risk factors for cardiovascular diseases as ex-
plained earlier, and having been seen by their physicians
between 1974 to 2000. Among the 2000 charts, only 128
males and 112 females were having pertinent data at the
different 7 age-groups, permitting longitudinal study of
all the subjects used in this study. These charts were re-
viewed by 2 reviwers. A sample of 20 charts were reviewed
by the two reviewers to determine variability between re-
viewers. The inter-chart reviewer differences was less than
0.2%. Data from the subjects were presented by specific
age group, which we think may approximate the criteria of
Tanner [35] for genital development. WC:AC ratio was re-
moved from the anthropometric measurements because
the concept of waist circumference, waist to hip ratio or
waist circumference to arm circumference was unknown
or not used to quantify central adiposity.
Statistical procedures
SAS PROC MIXED version 6.11 (SAS Institute, Cary,
North Carolina) was used to analyze longitudinal and
correlated data. The analyses were interpreted using P <
0.01 as the level of significance. An unpaired T-test was
used to analyze the difference between male and female
for each variables measured at each Tanner stages. Pearson
correlations were computed to evaluate the relationship
between specific continuous variables. Odds ratios were
used to quantify risk in our population.
Results
Study 1
Table 1 shows the main anthropometric measurements of
our study population. Pubertal status was appropriate for
age in all subjects; all girls over 14 y had reached me-
narche and all boys over 14 y had Tanner Stage grades of
3 or more. The distribution of obese and overweight ado-
lescents in our study did not differ from that expected in
an average North American population. As defined in
methods WC:AC ratio which is an indicator of central ad-
iposity was significantly higher in both (P < 0.01) over-
weight and (P < 0.001) obese adolescents in comparison
with controls, either in adolescents of different Tanner's
stages or adults of both sexes. The CPR value which is rep-
resentative of central-peripheral obesity was also signifi-
cantly higher (P < 0.01) in both overweight and (P <
0.001) obese adolescents. The same is true for the STR andBMC Family Practice 2002, 3 http://www.biomedcentral.com/1471-2296/3/18
Page 7 of 14
(page number not for citation purposes)
SUM values. For all the anthropometric measurements
there were no significant differences between sexes.
Table 2 indicates that the prevalence of impaired glucose
and lipid profiles were highest among those with a BMI
above the 95th. The prevalence of impaired fasting glucose
is already significant at Tanner stage 1 with percentage
prevalence of 11.1% and 44.1% for overweight and obese
subjects respectively. The prevalence was significantly
higher in both (P < 0.01) overweight and (P < 0.001)
obese adolescents in comparison with controls, either in
adolescents of different Tanner's stages or adults of both
sexes. The prevalence of impaired fasting glucose did not
differ significantly between adolescents and adults, either
in male or female. Adolescents with BMI exceeding the
85th percentile are at increased risk of being classified as
Table 4: Sensitivity, specificity, and odds ratios for impaired lipid profile (ILP) vs normal lipid profile (NLP) for both sex at Tanner's 
stages 3 to 5 with a selected cutoff point for BMI values at the 85th percentile.
Tanner's stages Cutoff point for BMI values Sensitivity Specificity Odds ratio
> 85th < 85th.
Tanner III
Males
ILP(n = 34) 31 3 91.2%
NLP (n = 77) 41 36 46.7%
Total (n = 111) 72 39 9.1
Females
ILP(n = 36) 31 5 86.1%
NLP (n = 66) 34 32 48.5%
Total (n = 102) 65 37 5.9
Tanner IV
Males
ILP(n = 48) 43 5 89.6%
NLP (n = 59) 31 28 47.5%
Total (n = 107) 64 33 7.8
Females
ILP(n = 43) 39 4 87.5%
NLP (n = 46) 18 28 83%
Total (n = 89) 47 32 15.2
Tanner V
Males
ILP(n = 54) 48 6 88.8%
NLP (n = 55) 23 32 58.2 %
Total (n = 109) 71 38 11.1
Females
ILP(n = 50) 45 5 84.8%
NLP (n = 51) 22 28 66.2%
Total (n = 101) 68 33 11.5
Adults
Males
ILP(n = 65) 59 6 86.4%
NLP (n = 67) 29 38 67.0%
Total (n = 132) 88 44 12.9
Females
ILP(n = 60) 54 6 85%
NLP (n = 62) 28 34 65.8%
Total (n = 122) 82 40 10.9
Normal lipid profile values were those < 75th percentile for age and sex, moderate risk > 75th percentile and < 90th percentile, and high risk  90th 
percentile. For comparison between adolescent and adults percentiles were used. ILP was determined as being  85th percentile adjusted for age 
and sex. Normal blood cholesterol level in adults = TC < 200 mg/dl (5.2 mmol/L), moderate risk as 5.2 to 6.2 mmol/L and high risk if > 6.2 mmol/l 
(240 mg/dl). For LDL cholesterol; normal if < 3.4 mmol/L (130 mg/dl), moderate risk as 3.4 to 4.1 mmol/L and high risk if > 4.1 mmol/L (159 mg/dl). 
HDL cholesterol was defined at high risk if < 0.9 mmol/L (35 mg/dl). TRG levels was normal if < 2.8 mmol/l (250 mg/dl), moderate risk as 250–500 
mg/dl and high risk if > 5.6 mmol/L (500 mg/dl). [38]BMC Family Practice 2002, 3 http://www.biomedcentral.com/1471-2296/3/18
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having diabetes or impaired fasting glucose. Also the prev-
alence of lipid profile abnormalities was highest among
those above the 95th percentile for BMI. Adolescents with
BMI exceeding the 85th percentile are at increased risk of
having abnormal lipid profiles. Again, the difference be-
tween the three groups was already present at Tanner stage
1. The presence of an abnormal lipid profile was observed
from Tanner stages III and above.
Sensitivity refers to the percentage of obese or overweight
participants who were correctly predicted to be at risk for
either glucose or lipid profiles abnormalities. Specificity
refers to the percentage of participants who were correctly
predicted to be in the remaining groups. BMI > 85th per-
centile were chosen as cutoff point for identifying over-
weight adolescents and BMI < 85th percentile were
considered as normal subjects. Table 3 shows that the sen-
sitivity and specificity to predict impaired fasting glucose
at Tanner stages III and above were at least 60% and 80%,
respectively. With use of this cutoff point, the odds ratio
of being at risk for impaired fasting glucose varied from
11.7 to 23.7 for males and females.
Table 4 shows that the sensitivity and specificity to predict
an impaired lipid profiles at Tanner stages III and above
were from 47.5% to 83% (males) and from 84.8% to
91.2% (females), respectively. Using a BMI at the 85th per-
centile as a cutoff point, the odds ratio for impaired lipid
profiles varied from 9.1 to 15.2 for males and females.
The associations between anthropometric measurements,
fasting glucose and insulin levels, and lipid profiles, at
each Tanner stage are presented in Tables 5 and 6 respec-
tively, with (P < 0.01 and less) for each group. Regression
analyses were not required to establish significance.
Study 2
Table 7 shows the main anthropometric measurements of
our study population at 7 different interval age groups
from 9 to 38 years old. The BMI adjusted for age and sex
was appropriate at each interval age group. CPR STR and
Table 5: Correlation between anthropometric variables and fasting glucose levels, insulin levels and lipid profile in male adolescents in-
cluding all Tanner's stages.
Variables BMI WC:AC CPR STR SUM
Glucose 0.80 0.95 0.98 0.94 0.95
Insulin 0.71 0.94 0.97 0.96 0.96
TRG 0.82 0.93 0.95 0.92 0.95
TC 0.87 0.96 0.98 0.91 0.96
HDL 0.77 0.93 0.90 0.91 0.93
LDL 0.82 0.90 0.89 0.85 0.91
T:HDLC 0.73 0.88 0.86 0.87 0.90
All correlation coefficients were statistically significant at least P < 0.01. See text for abbreviations.
Table 6: Correlation between anthropometric variables and fasting glucose levels, insulin levels and lipid profile in female adolescents 
including all Tanner's stages.
Variables BMI WC:AC CPR STR SUM
Glucose 0.80 0.87 0.82 0.75 0.92
Insulin 0.70 0.85 0.84 0.85 0.92
TG 0.78 0.94 0.95 0.76 0.93
TC 0.82 0.92 0.85 0.75 0.91
HDL 0.74 0.91 0.92 0.84 0.91
LDL 0.82 0.91 0.86 0.79 0.91
T:HDLC 0.75 0.92 0.92 0.86 0.93
All correlation coefficients were statistically significant at least P < 0.01. See text for abbreviations.BMC Family Practice 2002, 3 http://www.biomedcentral.com/1471-2296/3/18
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SUM were significantly increased (P < 0.01) with age cor-
responding with a higher fat mass with growth. For all the
anthropometric measurements there were no significant
gender differences.
Table 8 presents the incidence of impaired glucose and li-
pid profile between age groups. The incidences of im-
paired glucose and lipid profiles were already high at the
first age group with incidences of approximately 30 % for
both. The incidence increases progressively with age.
Fasting plasma glucose level (results not shown), HbA1c
and fasting plasma insulin levels were significantly in-
creased (P < 0.01) through puberty and growth. There
Table 7: Anthropometric measurements by age group and sex from childhood to adulthood.
Age group Age (years) BMI(%) CPR (ratio) STR (index) SUM
Male
9–12 years (N = 128) 10.6  0.6 86.4  1.1 2.3  0.07 1.5  0.05 89  8
13–15 years (N = 128) 14.3  0.4 87.7  1.3 2.4  0.05 1.6  0.04 110  6
16–19 years (N = 128) 18.1  0.5 88.6  1.7 2.5  0.07 1.5  0.04 123  7
20–23 years (N = 128) 22.9  0.7 86.3  2.2 2.7  0.06 1.8  0.05 139  10
24–27 years (N = 128) 26.3  0.6 87.0  2.4 2.8  0.06 1.9  0.07 155  9
28–31 years (N = 128) 28.5  1.4 87.5  2.6 3.2  0.07 2.3  0.07 173  11
32–38 years (N = 128) 35.0  2.6 87.0  2.6 3.2  0.09* 2.4  0.08* 190  12*
Female
9–12 years (N = 112) 11.3  0.7 85.6  1.4 2.4  0.06 1.3  0.05 91  5
13–15 years (N = 112) 13.6  0.4 85.8  2.3 2.5  0.07 1.5  0.06 112  7
16–19 years (N = 112) 17.8  0.4 87.9  1.8 2.5  0.04 1.6  0.04 125  9
20–23 years (N = 112) 21.2  0.6 87.5  2.2 2.7  0.06 1.9  0.07 144  9
24–27 years (N = 112) 25.3  0.4 87.9  2.1 2.8  0.07 1.8  0.06 160  11
28–31 years (N = 112) 29.3  0.4 87.2  1.7 2.9  0.08 2.1  0.06 174  10
32–38 years (N = 112) 35.1  0.5 87.5  2.1 3.1  0.07* 2.4  0.07* 192  13*
CPR: subscapular skinfold + suprailliac skinfold) / (triceps skinfold+ thigh skinfold), STR: ratio of subscapular to triceps skinfold, SUM:triceps, sub-
scapular, suprailliac and thigh skinfolds in the total sample. * : P < 0.01 significative difference between adulthood obesity and adolescent obesity.
Table 8: Incidence of impaired glucose and lipid profile by age group and sex from childhood to adulthood.
Impaired glucose profile Impaired lipid profile
N No Cases Incidence (%) No Cases Incidence (%)
Male
9–12 years 128 42 32.8 % 38 29.7 %
13–15 years 128 56* 43.7 % 52* 40.6 %
16–19 years 128 60 46.9 % 58 45.3 %
20–23 years 128 64 50.0 % 62 48.3 %
24–27 years 128 76* 59.4 % 76* 59.4 %
28–31 years 128 96* 75.0 % 94* 73.4 %
32–38 years 128 108* 84.4 % 110* 85.9 %
Female
9–12 years 112 36 32.1 % 36 32.1 %
13–15 years 112 48* 42.8 % 44* 39.3 %
16–19 years 112 52* 46.4 % 52* 46.4 %
20–23 years 112 56 50.0 % 54 48.2 %
24–27 years 112 66* 58.9 % 66* 58.9 %
28–31 years 112 84* 75.0 % 82* 73.2 %
32–38 years 112 94* 83.9 % 96* 85.7 %
* : P < 0.01 significative difference between age groups.BMC Family Practice 2002, 3 http://www.biomedcentral.com/1471-2296/3/18
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were no significant differences between sexes. TRG, TC,
LDL and T:HDLC were also significantly increased (P <
0.01) with growth. The reverse was observed for HDL.
BMI values at the 85th percentile for 13–15 year old group
were chosen as cutoff points for identifying overweight at
age 35 y. The sensitivities were 77.7% and 83.3%, and the
specificities 80.0% and 80.0%, for males and females re-
spectively. With use of the cutoff point of the 85th percen-
tile at this age group, the odds ratios for overweight at age
35 y were 12.8 for males and 20.0 for females (Table 9).
Table 10 presents the sensitivity, specificity and odds ra-
tios for the selected cutoff point for predicting impaired
fasting glucose (IFG) values at the 85th percentile at 13–15
year old group, at age 35. The sensitivities were 77.8% and
71.4%, and the specificities 76.4% and 77.6% for males
and females respectively. The odds ratios for abnormal
IFG at age 35 y were 11.3 for males and 8.6 for females.
Table 11 presents the sensitivity, specificity and odds ra-
tios for predicting impaired lipid profiles (ILP) at the 85th
percentile at 13–15 year old group, for age 35. The sensi-
tivities were 80.0% and 75%, and the specificities 77.7%
and 79.2%, for males and females respectively. With use
of the cutoff point of the 85th percentile at 13–15 year old
group, the odds ratios of ILP at age 35 y were 14.0 for
males and 11.4 for females.
Discussion
This study presents for the first time that: 1) obese and
overweight adolescents at Tanner stages III and higher are
at an increased risk of having impaired glucose and lipid
profiles at maturity than normal subjects. Odds ratios of
9.0 and higher were measured in both genders. 2) all the
Table 9: Sensitivity, specificity, and odds ratios of the selected cutoff point for BMI values at the 85th percentile at 13–15 y old for iden-
tifying overweight at age 35 y
BMI at age 35 y BMI percentile at 13–15 y Sensitivity Specificity Odds ratio
.> 85th < 85th
Males
> 25 (n = 110) 88 24 80.0 %
< 25 (n = 18) 4 14 77.7 %
Total (n = 128) 92 38 12.8
Females
> 25 (n = 100) 80 20 80.0 %
< 25 (n = 12) 2 10 83.3 %
Total (n = 112) 82 30 20.0
Specificity = 88 of 110 subjects, Sensitivity: 14 of 18 subjects. An odds ratio of 12.8 means that the risk of 13–15 years old adolescents with a BMI  
85th percentile of becoming an overweight or obese adults at 35 y old is 12.8 times higher than in those with a BMI < than 85th percentile
Table 10: Sensitivity, specificity, and odds ratios of the selected cutoff point for impaired fasting glucose (IFG) values at the 85th percen-
tile at 13–15 y old for identifying IFG at age 35 y
BMI at age 35 y BMI percentile at 13–15 y Sensitivity Specificity Odds ratio
.> 85th < 85th
Males
> 25 (n = 110) 84 26 76.4 %
< 25 (n = 18) 4 14 77.8 %
Total (n = 128) 88 40 11.3
Females
> 25 (n = 98) 76 22 77.6 %
< 25 (n = 14) 4 10 71.4 %
Total (n = 112) 80 32 8.6BMC Family Practice 2002, 3 http://www.biomedcentral.com/1471-2296/3/18
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anthropometric parameters tested were strongly (P <
0.01) associated with glucose and lipid profiles; 3), with a
retrospective-prospective longitudinal study of the same
subjects, the odds ratios of adolescents aged between 13
and 15 years old with a BMI  85th percentile to becoming
overweight or obese at 35 y old were 12.8 and 20.0 times
higher than in those with a BMI < than 85th percentile for
both male and female respectively, 4) with use of the
same cutoff, the odds ratios of the same adolescents with
BMI  85th percentile for impaired fasting glucose at 35 y
old were 11.3 times higher in males and 8.6 times higher
in females and 5) the odds ratio of the same adolescents
of having impaired lipid profiles, expressed by lipid pro-
file values  85th percentile at 35 y old is 14.0 in males and
11.4 in females. These observations suggest that between
13 to 15 years old is an appropriate age to initiate inter-
ventions in order to prevent adult obesity and its associat-
ed risk factors.
Study 1
The rationale underlying this part of the study is that the
stage of sexual maturation is an important variable in ap-
plying anthropometric measurements as predictors of risk
for cardiovascular diseases. On average, BMI seems to in-
crease with stage of genital maturation in boys relative to
fatness, and then, in contrast, decreases in the later stages
of maturation reflecting the rapid growth of fat free mass
with puberty. BMI in girls also increases with stage of sex-
ual maturation, but relative fatness is variable, especially
in girls who just attaining menarche (stage III). To obviate
this bias, we preselected our subjects according to their
BMI. For instance a BMI  85th percentile (for age and sex)
was classified as being overweight, and those with a BMI
 95th percentile as obese [29–32]. Recent workshops con-
cluded that the BMI is an index of choice for evaluating
obesity in adolescents, because it has been validated by
studies of total body fat [32]. The criteria used to identify
overweight and obesity in children and adolescents agree
with those used for grade 1 and grade 2 overweight (BMI
of 25+ and 30+, respectively) in adults [33]. Using a rep-
resentative sample from the general North American Cau-
casian population, we demonstrate that the BMI is also a
good indicator for obesity in adolescents, however the
readily-measured WC:AC, CPR, and STR, indices of cen-
tral obesity, and SUM, a single measure of subcutaneous
adiposity, are stronger predictor of both fasting glucose
and insulin levels and lipid profiles, than BMI. We also
demonstrated that each anthropometric variable taken
separately can significantly predict fasting glucose and in-
sulin levels and lipid profile in adolescents of both sexes
with a probability of P < 0.01. Our results are in accord-
ance with others of children aged 5 and 16, in whom, in-
dicators of fatness such as weight-for-height, BMI and
skinfold thicknesses have been associated with higher to-
tal and LDL cholesterol, lower HDL cholesterol, and high-
er triglyceride concentrations [40–43].
Our overweight and obese adolescents had higher fasting
glucose, and insulin levels for BMI than subjects with BMI
in the healthy range. Furtheremore, the prevalence of
obesity was comparable between boys and girls. In both
sexes the prevalence of diabetes and impaired fasting glu-
cose increased relative to chronological age in both over-
weight (P < 0.01) and obese subjects (P < 0.001). Previous
study in Aboriginal children recognized to be at high risk
for type II diabetes has shown that obesity is associated
with high fasting glucose and fasting insulin levels. They
also demonstrated that children with BMI exceeding the
85th percentile are at increased risk of diabetes or im-
paired fasting glucose, odds ratio of 5.1 with 95% coeffi-
cient interval 1.5, 17.0 [39]. With use of the cutoff point
of the 85th percentile we demonstrated that adolescents of
Tanner stage III and higher, of both sexes, are at increased
Table 11: Sensitivity, specificity, and odds ratios of the selected cutoff point for Impaired lipid profile (ILP) values at the 85th percentile 
at 13–15 y for identifying (ILP) at age 35 y
BMI at age 35 y BMI percentile at 13–15 y Sensitivity Specificity Odds ratio
.> 85th < 85th
Males
> 25 (n = 108) 84 24 77.7 %
< 25 (n = 20) 4 16 80.0 %
Total (n = 128) 88 40 14.0
Females
> 25 (n = 96) 76 20 79.2 %
< 25 (n = 16) 4 12 75.0 %
Total (n = 112) 80 32 11.4BMC Family Practice 2002, 3 http://www.biomedcentral.com/1471-2296/3/18
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risk of having impaired fasting glucose, with odds ratios of
11.7 and higher.
Our overweight and obese adolescents had higher TC,
LDL, TRG and lower HDL values which correlated with
BMI, and other measures of fatness. In both sexes the
prevalence of impaired lipid profile increased relative to
chronological age in both overweight (P < 0.01) and
obese subjects (P < 0.001) l. Adolescents of both sexes,
with BMI  85th are at increased risk of impaired fasting
lipid profiles, with odds ratios of 9.1 and higher.
Study 2
The goal of the second study was to determine the child-
hood age of abnormal glucose and lipid profiles from
overweight adults. By using a retrospective-prospective
longitudinal study design we were able to track BMI, glu-
cose and lipid profiles from late childhood and adoles-
cent ages to adulthood in a white Caucasian populations.
Then we were able to correlate their subsequent risk of
obesity and its associated impaired glucose and lipid pro-
files There is general agreement on the use of BMI with se-
lected cutoff points as guidelines for desirable weight [44–
48]. This study provided a basis for prediction of over-
weight and obesity in adults from their 13–15 year old
group, suggesting that this simple measurement could be
applied to the prediction of obesity in public health pro-
grams. The results presented here were comparable to
those observed in a previous study showing that with use
of the cutoff point of the 60th percentile at age 18 y, the
odds ratios of overweight at age 35 y were of 15 for males
and 27 for females, with corresponding SEs of 1.9 and 3.5
respectively. Previous data on 8–18 y olds in Project
Heart-Beat demonstrated that the odds ratio of over-
weight in adulthood for those with childhood BMI values
at the 95th percentile were 2–6 and 1.5 to 5 times as great
as for those with a BMI values at the 75th percentile for
males and females respectively [49].
The incidence of impaired glucose profile was comparable
between boys and girls. In both sexes the incidence of di-
abetes and impaired fasting glucose increased significant-
ly (P < 0.001) relative to chronological age in comparison
to adults. The sensitivity of the selected cutoff point for
BMI values at the 85th percentile at 13–15 years old for
identifying impaired glucose profile at age 35 y was 76.4%
and 77.6% for both male and female, respectively. There-
fore, at least 75% of male and female adolescents aged be-
tween 13 and 15 years old who were having a BMI  85th
were correctly predicted to have impaired glucose profile
at 35 y. On the other hand, 77.8% of male and 71.4% of
female adolescents of this age group who were having a
BMI  85th were correctly predicted to have normal glu-
cose profile at 35 y. As stated in the introduction obesity
in childhood is associated with obesity in adulthood [22–
25], and is a predictor of all cause of obesity-associated
mortality during adulthood, particularly mortality from
cardiovascular diseases, which is independent of adult
weight [24,25]. The results of the present study agreed
with a previous study [50] indicating that the metabolic
alterations caused by excess body fat are expressed early in
the natural history of obesity. Such alterations seem clini-
cally important even in children, as evidenced by an in-
crease in glucose profile abnormalities in obese
adolescents. These observations underscore the need for
research efforts directed at the development of effective in-
terventions for obese adolescents.
The incidence of impaired lipid profile was comparable
between boys and girls. In both sexes the incidence of im-
paired lipid profile increased significantly (P < 0.001) rel-
ative to chronological age in comparison to adults. The
sensitivity of the selected cutoff point for BMI values at the
85th percentile at 13–15 years old for identifying impaired
lipid profile at age 35 y was 77.7% and 79.2% for both
male and female, respectively. The specificity was 80.0%
and 75.0%, for both male and female, respectively. If we
consider that most of the subjects having a BMI  85th
were also presenting more than 2 risk factors for cardio-
vascular disease, this means that they are at increased risk
for developing cardiovascular diseases. Few studies have
examined the long-term effects of adolescent obesity on
adult disease. Nonetheless, obesity present in childhood
or adolescence seems to increase the likelihood of adult
morbidity and mortality [51]. In the present study we
demonstrated that in both men and women obese during
adolescence, risk of cardiovascular diseases and diabetes
were increased. These effects seems related both to the
persistence of obesity and to the effects of childhood or
adolescent obesity on the quantity and location of body
fat distribution. The risk factors for adult disease that are
associated with obesity in children and adolescents persist
into adulthood or increase in prevalence if weight gain oc-
curs. Although both total body fat and regional fat depo-
sition could account for the association of childhood or
adolescent obesity with adult disease, no studies to date
have examined cardiovascular risk factors and related
them to visceral fat.
Conclusion
The strengths of the study include the use of large samples
of both genders, a wide age range, subjects representative
of the population being studied, precise measurements of
body composition and the use of well-accepted BMI clas-
sifications of overweight and obesity. By using a retrospec-
tive-prospective design in the second part of the study we
were able to obtain the longitudinal data required to an-
swer the questions addressed. In conclusion our study
confirms the hypothesis that overweight and obese ado-
lescents have higher fasting plasma glucose and insulinBMC Family Practice 2002, 3 http://www.biomedcentral.com/1471-2296/3/18
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levels, and an abnormal lipid profile relative to their lean
peers. This study highlights the critical importance of early
identification and intervention of adolescent obesity to
avert the long-term consequences of it and to protect ado-
lescent against the risk of cardiovascular diseases. There is
an urgent need to follow cohorts at-risks children and ad-
olescents to investigate cofactors acting in concert with
obesity that are responsible for the early onset of risk fac-
tors for cardiovascular diseases, a phenomenon increas-
ingly being observed in many populations.
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